key: cord-0841539-cxpklg3l authors: Chan, Wan‐Mui; Ip, Jonathan Daniel; Chu, Allen Wing‐Ho; Yip, Cyril Chik‐Yan; Lo, Lap‐Sum; Chan, Kwok‐Hung; Ng, Anthony Chin‐Ki; Poon, Rosana Wing‐Shan; To, Wing‐Kin; Tsang, Owen Tak‐Yin; Leung, Wai‐Shing; Kwan, Mike Yat‐Wah; Chua, Gilbert T.; Chung, Tom Wai‐Hin; Hung, Ivan Fan‐Ngai; Kok, Kin‐Hang; Cheng, Vincent Chi‐Chung; Chan, Jasper Fuk‐Woo; Yuen, Kwok‐Yung; To, Kelvin Kai‐Wang title: Identification of nsp1 gene as the target of SARS‐CoV‐2 real‐time RT‐PCR using nanopore whole genome sequencing date: 2020-06-05 journal: J Med Virol DOI: 10.1002/jmv.26140 sha: efe3fe69b48d225afd625697115ca019e90b2e36 doc_id: 841539 cord_uid: cxpklg3l Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused the COVID‐19 pandemic. Accurate detection of SARS‐CoV‐2 using molecular assays is critical for patient management and the control of the COVID‐19 pandemic. However, there is an increasing number of SARS‐CoV‐2 viruses with mutations at the primer or probe binding sites, and these mutations may affect the sensitivity of currently available real‐time reverse transcription–polymerase chain reaction (RT‐PCR) assays targeting the N, E, and ORF1a/b genes. Using sequence‐independent single‐primer amplification (SISPA) and nanopore whole‐genome sequencing, we have found that the nsp1 gene, located at the 5’ end of the SARS‐CoV‐2 genome, was highly expressed in the nasopharyngeal or saliva specimens of 9 COVID‐19 patients of different clinical severity. Based on this finding, we have developed a novel nsp1 real‐time RT‐PCR assay. The primers and probes are highly specific for SARS‐CoV‐2. Validation with 101 clinical specimens showed that our nsp1 RT‐PCR assay has a sensitivity of 93.1% (95% confidence interval, 86.2‐97.2%), which was similar to those of N and E gene RT‐PCR assays. The diagnostic specificity was 100% (95% CI, 92.9‐100%). The addition of nsp1 for multi‐target detection of SARS‐CoV‐2 can avoid false negative results due to mutations at the primers/probes binding sites of currently available RT‐PCR assays. This article is protected by copyright. All rights reserved. In 2003, severe acute respiratory syndrome coronavirus (SARS-CoV) cross species barrier and became the first coronavirus to cause high fatality rate in humans 1 . In 2020, SARS-CoV-2, first reported from Hubei province of China in December 2019, has become the first coronavirus to cause a pandemic 2, 3 . Most patients with coronavirus disease 2019 (COVID-19) present with respiratory symptoms, while 18% exhibit gastrointestinal symptoms 4 . Radiologically, COVID-19 is characterized by multifocal and peripheral ground glass opacities, but 2.9% of severe cases did not show any abnormalities in their lung computed tomography 2, 5 . Complications include acute respiratory distress syndrome, arrhythmia, secondary bacterial infection, and multiorgan failure [6] [7] [8] [9] . Pathologically, COVID-19 was characterized by diffuse alveolar damage, interstitial lymphocyte infiltrates, and multinucleated syncytial cells in the lung, and microvascular steatosis in the liver 10 . diagnosis. The aim of this study is to identify novel targets for molecular detection of SARS-CoV-2. In our previous study, we have successfully identified highly-expressed gene regions for influenza A virus using nanopore sequencing, and have developed highly sensitive and specific novel PB2 and NS RT-PCR for detection of human and zoonotic influenza A viruses 20 . Using the same strategy, we first used nanopore sequencing to identify highly expressed gene regions of the SARS-CoV-2 genome in clinical specimens. After identifying non-structural protein 1 (nsp1) gene as a highly expressed gene region, we have designed the nsp1 RT-PCR which demonstrated high sensitivity and specificity using clinical specimens. For nanopore sequencing, we have retrieved 22 original clinical specimens of 14 patients with high viral load. For the determination of analytical specificity, we have retrieved the total nucleic acid (TNA) that were extracted from 13 nasopharyngeal aspirate specimens previously found to be positive for human coronaviruses (OC43, NL63, HKU1, 229E) by FilmArray ® Respiratory Panel 2 (RP2) (BioFire ® , Biomerieux), which were between November 2018 and December 2019 (Supplementary Table S1 ). For clinical validation, we retrieved specimens that tested positive for SARS-CoV-2 using our in-house RdRp/Hel assay reported previously 14 Nanopore sequencing was performed as we described previously with modifications 2, 3 . To deplete host cells, nasopharyngeal or saliva specimens were centrifuged at 16,000 × g for 2 min, and supernatant was used for subsequent RNA extraction. RNA was extracted from 140 µL of supernatant using QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) as we described previously. RNA was DNase This article is protected by copyright. All rights reserved. Sequence-independent single-primer amplification (SISPA) was performed as described previously 2, 3 . Briefly, DNase-treated RNA was reverse transcribed to single strand cDNA using primer A (5'-GTTTCCCACTGGAGGATA-N9-3'). Second strand cDNA synthesis was performed using Klenow Fragment (3'→5' exo-) (New England BioLabs, Ipswich, Massachusetts). PCR using primer B (5'-GTTTCCCACTGGAGGATA-3') was used in generating the amplified cDNA libraries. Nanopore sequencing library preparation was performed according to manufacturer's instructions for Ligation Sequencing Kit (SQK-LSK109, Oxford Nanopore Technologies). Briefly, amplified PCR products were purified by 1x AMPure XP bead (Beckman Coulter, California, CA). Equal molar of each amplified PCR products were then subjected to DNA repair, end preparation, and native barcode ligation (EXP-NBD104, Oxford Nanopore Technologies). Barcoded samples were pooled and were ligated to sequencing adaptor. Sequencing was performed with Oxford Nanopore MinION device using R9.4.1 flow cell for 12-48 hours. After sequencing, Guppy v3.4.5 was used in converting the raw signal data into FASTQ format, demultiplexing, removal of nanopore and SISPA adaptor sequences. Only reads with a minimum Q score of 7 were included for subsequent analysis. The sequencing run was quality-checked using MinIONQC 22 . Human reads were depleted by mapping to reference human genome hg38, and unmapped reads were extracted using SAMTools 23 . The non-human reads were mapped to the reference genome SARS-CoV-2 isolate Wuhan-Hu-1 (NCBI GenBank: MN908947.3). BCFtools Mpileup was used in creating a variant file 24 . BCFtools call 24 , vcfutils.pl 23 , and Seqtk seq 25 were used in generating the FASTA consensus sequence. Finally, the coverage data was obtained Accepted Article using SAMtools 23 . Only specimens with a mean coverage of 250x were included for further analysis. The consensus sequences of 5 specimens from four patients (HKU-902a, HKU-903a, HKU-903b, HKU-907b and HKU-908a) were previously deposited into NCBI GenBank (Accession number: MT114412, MT114414, MT114415, MT114417, MT114418) 3 . The consensus sequences of HKU-904a, HKU-905a, HKU-911a, HKU-913a, and HKU-915a have been deposited into NCBI GenBank (Accession number: MT365028-M T365032 ). Raw reads, after excluding human reads, have been deposited into BioProject (Bioproject ID: PRJNA627286). The phylogenetic tree of the whole SARS-CoV-2 genome was constructed using neighbour-joining method using MEGA software package version 7.0. The bootstrap values from 1000 replicates were calculated to evaluate the reliability of the phylogenetic trees. Phylogenetic types A, B and C were defined as described previously 18 . Primers and probes targeting the nsp1 region was designed by multiple alignment The limit of detection (LOD) was determined using serially-diluted SARS-CoV-2 virus culture isolates as described previously 14, 27 . SARS-CoV-2 virus was cultured in VeroE6 cells. The concentration of the virus culture stock was 1.8×10 7 50% tissue culture This article is protected by copyright. All rights reserved. Table 1 . Real-time RT-PCR for E gene was performed according to a published protocol, except that the total reaction volume was reduced to 20 μl instead of 25 μl 13, 28 . Briefly, superscript III one-step RT-PCR system with Platinum™ Taq Polymerase (Thermo To identify gene regions that were highly expressed, coverage map was visualized using integrative genomics viewer (IGV). The nsp1 gene region was highly expressed in all specimens ( Figure 3A ). Specific primers and probes targeting SARS-CoV-2 were selected by aligning This article is protected by copyright. All rights reserved. A total of 101 archived respiratory tract specimens collected between 29 th January and 7 th April, 2020, and tested positive for SARS-CoV-2 by our-house RdRp/Hel assay, were retrieved. Of these 101 COVID-19 patients, SARS-CoV-2 was detected by at least one of nsp1, N or E gene RT-PCR assays in 99 patients (98.0%), and 85 patients (84.2%) were detected by all 3 RT-PCR assays ( (Table 3) . To determine the diagnostic specificity of the assay, we tested nsp1 gene real time RT-PCR on 50 nasopharyngeal specimens from non-COVID-19 patients. All 50 specimens tested negative by nsp1 RT-PCR, and therefore the specificity was 100% (95% CI, 92.9-100%) In this study, we have developed a highly sensitive and specific nsp1 real-time RT-PCR for the detection of SARS-CoV-2. We first identified nsp1 to be a highly expressed gene target in clinical specimens using nanopore whole genome sequencing, and designed a real-time RT-PCR protocol based on nsp1 gene. This novel nsp1 real-time RT-PCR did not cross react with other human coronaviruses or other respiratory viruses, and has a sensitivity of 93.1%, which is similar to real-time RT-PCR targeting N and E genes. In silico analysis of the primers/probe regions showed that nsp1 is better than N gene which has fewer mutations in the 3' end of the primers/probe region ( Figure 1A ). This article is protected by copyright. All rights reserved. Together with the analysis done by GISAID 19 , which showed higher mutation rate in the published N gene primers/probe region, nsp1 can serve as an alternative target for the detection of SARS-CoV-2. Identifying alternative targets for the detection of SARS-CoV-2 is important because genetic variations can affect the sensitivity of RT-PCR. There are two major sources of genetic variations in coronaviruses. First, the mutation rates in CoV are moderate to high compared to other single-stranded RNA viruses. It was estimated that the average substitution rate of SARS-CoV and MERS-CoV is about 10 -3 substitutions per year per site 30 . Second, recombination is well known to occur for coronaviruses. These recombination events can occur between viruses in the same genus, same lineage, or even in different lineages 30 . The recombination occurs in both animal and human coronaviruses 31, 32 . SARS-CoV-2 is also believed to arise due to recombination event that involves the receptor binding motif of a closely related BatcoV RaTG13 33 . Recombination is especially important because the current real-time RT-PCR targets are mainly located in the middle or 3' end of the genome. In contrast, nsp1 gene is located in the 5' end, and therefore may not be affected by recombination events occurring between the nsp1 gene and RdRp gene. Unlike other targets commonly used for diagnosis, the nsp1 is located in the 5' end of the genome. These gene targets are located in the middle or 3' end of the viral genome 34 . Since recombination can occur, it is important to have a target at the 5' end of the genome. Nsp1 is usually not considered to be highly expressed. However, our nanopore sequencing of clinical specimens has consistently shown that nsp1 gene region is highly expressed. Traditionally, it was thought that the subgenomic sequences arise from the This article is protected by copyright. All rights reserved. Accepted Article leader sequence. However, recently, it was shown that the subgenomic sequences arise at the nsp1-truncated nsp2 and/or truncated nsp3 region 35 . Shortly after the announcement of SARS-CoV-2 as the causative pathogen of COVID-19, Shirato et al has reported the use of a conventional nested RT-PCR targeting nsp1 gene, but require Sanger sequencing for confirmation 29 . In this early report, the sensitivity and specificity of their conventional nsp1 gene nested RT-PCR was not reported. The coverage map for SARS-CoV-2 from our study using of SISPA and nanopore sequencing suggests that nsp1 was highly expressed in clinical specimens. In contrast, in a previous study, nsp1 was not shown to be highly expressed in the coverage map from Illumina sequencing 36 . One possibility is the difference in library preparation. In the paper by Wu et al, ribosomal RNA depletion was performed to reduce the amount of human RNA in the specimen before reverse transcription. Ribosomal RNA depletion has been shown to introduce biased distribution of read coverage for influenza virus 37 . In contrast, our library preparation did not involve ribosomal RNA depletion, which may have avoided this bias. Another potential technique to survey expression is direct RNA sequencing using nanopore technology. However, this technique requires a large amount of high quality and pure viral RNA as starting material, which is often unfeasible from clinical specimens. Moreover, the protocol utilizes oligodT primers to capture the polyA tail to allow the complex to be brought to the sequencing pore where the RNA is read from the 3' to 5' direction. This technology may not be useful in assessing abundance of particular This article is protected by copyright. All rights reserved. regions as efficiency of detection is higher in early reads resulting in coverage bias towards the 3' end of the genome. Studies from SARS-CoV indicate that NSP1 protein suppresses the antiviral response 34 . NSP1 can bind to 40S ribosome to block the assembly of ribosome and induce endonucleolytic cleavage and the degradation of host mRNAs. Furthermore, NSP1 can change the nuclear-cytoplasmic distribution of nucleolin 38 . Since nsp1 gene is highly expressed in our SARS-CoV-2 patients, it remains to be determined whether the function of NSP1 is also enhanced in SARS-CoV-2. There are several limitations of this study. First, although our nanopore SISPAbased whole genome sequencing allowed us to identify highly expressed gene regions, there can still be bias during the library preparation which may affect the coverage of each position in the viral genome. Second, our nanopore sequencing did not encompass phylogenetic type C strains, which is mainly found in Europe and in America. We have found that viral gene nsp1 is highly expressed in patients with COVID-19. Our novel real-time RT-PCR assay targeting nsp1 was highly sensitive and specific in the detection of SARS-CoV-2 in clinical specimens. Our real-time RT-PCR is unique in that nsp1 gene is located at the 5' end of the SARS-CoV-2 genome, while other currently published real-time RT-PCR protocols target genes located in the middle or 3' end of the viral genome. The incorporation of the nsp1 gene in multiplex RT-PCR assays will likely improve the detection of SARS-CoV-2. Coronavirus as a possible cause of severe CoV-2: an observational cohort study Gastrointestinal Manifestations of SARS CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet Respiratory medicine This article is protected by copyright. All rights reserved Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection 2019-nCoV Phylogenetic network analysis of SARS-CoV-2 genomes Full genome nucleotide alignments for high quality genomes Nanopore sequencing reveals novel targets for the diagnosis and surveillance of human and avian influenza A virus An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Radiology MinIONQC: fast and simple quality control for MinION sequencing data The Sequence Alignment/Map format and SAMtools BCFtools/RoH: a hidden Markov model approach for detecting autozygosity from next-27 Development of a Novel CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan Genetic Recombination, and Pathogenesis of Coronaviruses Identification of a Novel Betacoronavirus (Merbecovirus) in Amur Hedgehogs from China. Viruses Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2 Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect The architecture of SARS-CoV-2 transcriptome A new coronavirus associated with human respiratory disease in China Direct next-generation sequencing of virus-human mixed samples without pretreatment is favorable to recover virus genome